[1]
K. M. Thasneem, K. Sreejith, B. Athulnadh, N. Maniyan, C. C. Neena, and P. M. Faris, “SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease”, J. Drug Delivery Ther., vol. 10, no. 6, pp. 203–206, Nov. 2020, doi: 10.22270/jddt.v10i6.4532.